Opinion statement
Chronic intestinal pseudo-obstruction (CIP) is a gastrointestinal motility disorder characterized by chronic symptoms and signs of bowel obstruction in the absence of a fixed, lumen-occluding lesion. Radiographic findings consist of dilated bowel with airfluid levels. Pseudo-obstruction is an uncommon condition and can result from primary or secondary causes. The management is primarily focused on symptom control and nutritional support to prevent weight loss and malnutrition. The principles of management of patients with CIP involve 1) establishing a correct clinical diagnosis and excluding mechanical obstruction; 2) differentiating between idiopathic and secondary forms; 3) performing a symptomatic and physiologic assessment of the parts of the gastrointestinal (GI) tract involved by manometric and whole gut transit scintigraphic studies; 4) careful assessment of nutritional status of the patient; and 5) developing a therapeutic plan addressing the patient’s symptoms and nutritional status. Treatment of CIP includes frequent small meals with a low-fat, low-fiber diet, liquid nutritional supplements may be needed; prokinetic agents such as metoclopramide may help to reduce upper GI symptoms. Trials of drugs such as erythromycin, domperidone, cisapride, and tegaserod may be considered if there is no response. Subcutaneous octreotide may be helpful to improve small bowel dysmotility especially in patients with scleroderma. In patients with symptoms suggestive of bacterial overgrowth, courses of antibiotics such as metronidazole, ciprofloxacin, and doxycycline may be needed. Nutritional assessment and support is an important aspect of management. Enteral nutrition is usually preferred. In carefully selected patients, feeding jejunostomy with or without decompression gastrostomy may be tried. Long term parenteral nutrition should be reserved for patients who can not tolerate enteral nutrition. Complications associated with total parenteral nutrition include infections, sepsis, and cholestatic hepatic dysfunction.
Similar content being viewed by others
References and Recommended Reading
Rudolph CD, Hyman PE, Altshuler SM, et al.: Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: Report of consensus workshop. J Pediatr Gastroenterol Nutr 1997, 24: 102–112. This review describes consensus definition of CIP and focuses on CIP in children.
Stanghellini V, Camilleri M, Malagelada JR: Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987, 28: 5–12.
Coulie B, Camilleri M: Intestinal pseudo-obstruction. Annu Rev Med 1999, 50: 37–55.
Camilleri M, Phillips SF: Acute and chronic intestinal pseudo-obstruction. Adv Intern Med 1991, 36: 287–306.
Smith SD, Williams CS, Ferris CD: Diagnosis and treatment of chronic Gastroparesis and chronic intestinal pseudo-obstruction. Gastroenterol Clin North Am 2003, 32: 619–658. Most recent and comprehensive review of etiology, pathophysiology, and management of CIP.
Christensen J, Dent J, Malagelada JR, Wingate DL: Pseudo-obstruction. Gastroenterol Int 1990, 3: 107–119.
Besnard M, Faure C, Fromont-Hankard G, et al.: Intestinal pseudo-obstruction and acute pandysautonomia associated with Epstein-Barr infection. Am J Gastroenterol 2000, 95: 280–284.
Debinski H, Kamm M, Talbot I, et al.: DNA viruses in the pathogenesis of sporadic chronic intestinal pseudo-obstruction. Gut 1997, 41: 100–106.
Sodhi N; Camilleri M; Camoriano JK, et al.: Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989, 34: 1937–1942.
Mann SD, Debinski HS, Kamm MA: Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 1997, 41: 675–681.
Jain D, Moussa K, Tandon M, et al.: Role of interstitial cells of cajal in motility disorders of the bowel. Am J Gastroenterol 2003, 98: 618–624. Interesting paper emphasizing the role of interstitial cells of cajal in GI motility and importance of staining biopsy specimens for C-kit receptors in patients with suspected chronic idiopathic intestinal pseudo obstruction.
Di Lorenzo C: Pseudo-obstruction: current approaches. Gastroenterology 1999, 116: 980–987.
Schuffler MD: Chronic intestinal pseudo-obstruction. In Sleisenger and Fordtran’s Gastrointestinal and Liver disease. Edited by Feldman M. Philadelphia: WB Saunders 2002: 2140–2150. Detailed review of pathophysiology and histological abnormalities
Parkman HP, Harris AD, Krevsky B, et al.: Gastroduodenal motility and dysmotility: An update on techniques available for evaluation. Am J Gastroenterology 1995, 90: 869–892.
Bonapace ES, Davidoff S, Krevsky B, et al.: Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 2000, 95: 2838–2847.
Scolapio JS, Ukleja A, Bouras EP, et al.: Nutritional management of chronic intestinal pseudo-obstruction. J Clin Gastroenterol 1999, 28: 306–312.
Patrick PG, Marulendra S, Kirby DF, et al.: Endoscopic nasogastric-jejunal feeding tube placement in critically ill patients. Gastrointest Endosc 1997, 45: 72–76.
Warner E, Jeejeebhoy KN: Successful management of chronic intestinal pseudo-obstruction with home parenteral nutrition. JPEN 1985, 9: 173–78.
Cheng S, Philip C, Berquist WE, et al.: Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis Rheum 1989, 32: 312–16.
Feighner SD, Tan CP, McKee KK, et al.: Receptor for motilin identified in the human gastrointestinal system. Science 1999, 284: 2184–88.
Quigley EM: Chronic intestinal pseudo-obstruction. Curr Treat Options Gastroenterol 1999, 2: 239–250.
Emmanuel AV, Shand AG, Kamm MA: Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004, 15: 687–694.
Camilleri M, Malajelada JR, Abell TL, et al.: Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989, 96: 704–712.
Camilleri M, Balm RK, Zinmeister AR: Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology 1994, 106: 916–923.
Camilleri M, Balm RK, Zinmeister AR: Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal motility. Aliment Pharmacol Ther 1996, 10: 403–409.
Prather CM, Camilleri M, Zinsmeister AR, et al.: Tegaserod accelerates orocecal transit in patients with constipation predominant irritable bowel syndrome. Gastroenterology 2000, 118: 463–68.
Soudah HC, Hasler WL, Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991, 325: 1461–1467.
Verne JN, Eaker EY, Hardy E, et al.: Effect of octreotide and erythromycin on idiopathic and scleroderma associated intestinal pseudo obstruction. Dig Dis Sci 1995, 40: 1892–1901.
Ponec RJ, Saunders MD, Kimmey MB: Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999, 341: 137–141.
Thompson AR, Pearson T, Ellul J, Simpson JN: Percutaneous endoscopic colostomy in patients with chronic intestinal pseudo-obstruction. Gastrointest Endosc 2004, 59: 113–115.
Murr MM, Sarr MG, Camilleri M: The surgeon’s role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 1995, 90: 2147–2151.
Shibata C, Naito H, Funayama Y, et al.: Surgical treatment of chronic intestinal pseudo-obstruction: report of three cases. Surg Today 2003, 33: 58–61.
Grant D: Current results of intestinal transplantation: the International Intestinal Transplant Registry. Lancet 1996, 347: 1801–1803.
Niv Y, Mor E, Tzakis A: Small bowel transplantation-a clinical review. Am J Gastroenterol 1999, 94: 3126–3130.
Langnas AN: Advances in small intestine transplantation. Transplantation 2004, 77: S75-S78. Review of current status of small bowel transplantation for intestinal failure.
Anuras S, Camilleri M: Dysmotility of the small intestine. In: Textbook of Gastroenterology. Edited by Yamada T. Philadelphia: WB Saunders; 1999: 1584–1610.
Snape WJ Jr.: Disorders of gastrointestinal motility. In Cecil Text Book of Medicine. Edited by Bennett G. Philadelphia: Lippincott Williams & Wilkins; 2000: 694–702.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Panganamamula, K.V., Parkman, H.P. Chronic intestinal pseudo-obstruction. Curr Treat Options Gastro 8, 3–11 (2005). https://doi.org/10.1007/s11938-005-0046-4
Issue Date:
DOI: https://doi.org/10.1007/s11938-005-0046-4